Why the study?
COVID-19 affects the myocardium and worsens clinical outcomes, but differences in cardiac magnetic resonance imaging markers between COVID-19 and all-cause myocarditis remained to be identified.
Do cardiac magnetic resonance imaging markers differ between patients with COVID-19-associated myocardial injury and patients with clinically suspected all-cause myocarditis?
Do cardiac magnetic resonance imaging markers differ between patients with COVID-19-associated myocardial injury and patients with clinically suspected all-cause myocarditis?
Cardiac involvement in COVID-19 is characterized by less myocardial edema and fewer patients fulfilling Lake-Louise Criteria compared to typical all-cause myocarditis.
Answers are grounded in this paper and cite their sources.
CMRI reveals less edema in COVID-19 myocardial injury than other myocarditis; leaves open whether Lake Louise criteria require SARS-CoV-2-specific adjustment.
PURPOSE: Coronavirus 2019 disease (COVID-19) has been shown to affect the myocardium, resulting in a worse clinical outcome. In this registry study, we aimed to identify differences in cardiac magnetic resonance imaging (CMRI) between COVID-19 and all-cause myocarditis. MATERIALS AND METHODS: We examined CMRI of patients with COVID-19 and elevated high-sensitivity serum troponin levels performed between March 31st and May 5th and compared them to CMRI of patients without SARS-CoV-2 infection with suspected myocarditis in the same time period. For this purpose, we evaluated Lake-Louise Criteria for myocarditis by determining nonischemic myocardial injury via T1-mapping, extracellular volume, late gadolinium enhancement, and myocardial edema (ME) by T2-mapping and fat-saturated T2w imaging (T2Q). RESULTS: A total of 15 of 18 (89%) patients with COVID-19 had abnormal findings. The control group consisted of 18 individuals. There were significantly fewer individuals with COVID-19 who had increased T2 (5 vs. 10; P=0.038) and all-cause ME (7 vs. 15; P=0.015); thus, significantly fewer patients with COVID-19 fulfilled Lake-Louise Criteria (6 vs. 17; P<0.001). In contrast, nonischemic myocardial injury was not significantly different. In the COVID-19 group, indexed end-diastolic volume of the left ventricle showed a significant correlation to the extent of abnormal T1 (R2=0.571; P=0.017) and extracellular volume (R2=0.605; P=0.013) and absolute T1, T2, and T2Q (R2=0.644; P=0.005, R2=0.513; P=0.035 and R2=0.629; P=0.038, respectively); in the control group, only extracellular volume showed a weak correlation (R2=0.490; P=0.046). CONCLUSIONS: Cardiac involvement in COVID-19 seems to show less ME than all-cause myocarditis. Abnormal CMRI markers correlated to left ventricle dilation only in the COVID-19 group. Larger comparative studies are needed to verify our findings.
No takes yet. Share an insight, caveat, or question.
Maurus et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: